Decreased serum interleukin-41/Metrnl levels in patients with Graves' disease.

Luping GongGuoqing HuangLinjie WengJialu XuYan LiWugeng CuiMingcai Li

Published in: Journal of clinical laboratory analysis (2022)

This study demonstrates that GD patients have decreased serum IL-41 levels, and IL-41 plays a potential role in abnormal immune response of GD patients.

Keyphrases

end stage renal disease
immune response
ejection fraction
newly diagnosed
peritoneal dialysis
toll like receptor
inflammatory response